Serial Number | 79271337 |
Word Mark | ULTRASCAPE |
Filing Date | Wednesday, August 14, 2019 |
Status | 700 - REGISTERED |
Status Date | Tuesday, March 10, 2020 |
Registration Number | 6004774 |
Registration Date | Tuesday, March 10, 2020 |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, December 24, 2019 |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Laboratory research services in the field of biotechnology; laboratory research services in the field of immune profiling; laboratory research services in the field of vaccines; laboratory research services in the field of immunotherapy; laboratory research services in the field of immunotherapy products; laboratory research services relating to vaccines for use in the field of immunotherapy; laboratory research services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; laboratory research services, namely, probing for multiple T cell specificities for identification of tumor antigen-specific T cells for the treatment of cancer; laboratory research services, namely, probing for multiple T cell specificities for identification of viral antigen-specific T cells in the field of infectious diseases; laboratory research services, namely, phenotypic and functional T cell and/or other immune cells profiling for use in the field of immunotherapy; laboratory research services, namely, analysis by time-of-flight mass cytometry; laboratory research services, namely, analysis by flow cytometry; laboratory research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; laboratory research services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system |
Pseudo Mark | ULTRA SCAPE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, November 13, 2019 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | IMMUNOSCAPE PTE. LTD. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 24 - NOT AVAILABLE |
Address | SG |
Party Name | IMMUNOSCAPE PTE. LTD. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 24 - NOT AVAILABLE |
Address | SG |
Party Name | IMMUNOSCAPE PTE. LTD. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 24 - NOT AVAILABLE |
Address | SG |
Event Date | Event Description |
Friday, May 8, 2020 | NOTIFICATION PROCESSED BY IB |
Wednesday, April 22, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
Wednesday, April 22, 2020 | FINAL DISPOSITION PROCESSED |
Thursday, April 9, 2020 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
Tuesday, March 10, 2020 | REGISTERED-PRINCIPAL REGISTER |
Saturday, January 4, 2020 | NOTIFICATION PROCESSED BY IB |
Tuesday, December 24, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, December 18, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, December 18, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, December 4, 2019 | NOTICE OF PUBLICATION |
Thursday, November 21, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, November 19, 2019 | APPLICATION FILING RECEIPT MAILED |
Wednesday, November 13, 2019 | ASSIGNED TO EXAMINER |
Wednesday, November 13, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, November 7, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |